» Articles » PMID: 32579891

Near-infrared Fluorescence Imaging in Immunotherapy

Overview
Specialty Pharmacology
Date 2020 Jun 25
PMID 32579891
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Near-infrared (NIR) light possesses many suitable optophysical properties for medical imaging including low autofluorescence, deep tissue penetration, and minimal light scattering, which together allow for high-resolution imaging of biological tissue. NIR imaging has proven to be a noninvasive and effective real-time imaging methodology that provides a high signal-to-background ratio compared to other potential optical imaging modalities. In response to this, the use of NIR imaging has been extensively explored in the field of immunotherapy. To date, NIR fluorescence imaging has successfully offered reliable monitoring of the localization, dynamics, and function of immune responses, which are vital in assessing not only the efficacy but also the safety of treatments to design immunotherapies optimally. This review aims to provide an overview of the current research on NIR imaging of the immune response. We expect that the use of NIR imaging will expand further in response to the recent success in cancer immunotherapy. We will also offer our insights on how this technology will meet rapidly growing expectations in the future.

Citing Articles

Nano-fluorescence imaging: advancing lymphatic disease diagnosis and monitoring.

Han C, Choi S, Chi S, Hong J, Cho Y, Kim J Nano Converg. 2024; 11(1):53.

PMID: 39661218 PMC: 11635084. DOI: 10.1186/s40580-024-00462-1.


The Current Status and Future Directions on Nanoparticles for Tumor Molecular Imaging.

Yin C, Hu P, Qin L, Wang Z, Zhao H Int J Nanomedicine. 2024; 19:9549-9574.

PMID: 39296941 PMC: 11409933. DOI: 10.2147/IJN.S484206.


A Wireless, Multicolor Fluorescence Image Sensor Implant for Real-Time Monitoring in Cancer Therapy.

Roschelle M, Rabbani R, Gweon S, Kumar R, Vercruysse A, Cho N ArXiv. 2024; .

PMID: 38979489 PMC: 11230517.


From structural design to delivery: mRNA therapeutics for cancer immunotherapy.

Zhou F, Huang L, Li S, Yang W, Chen F, Cai Z Exploration (Beijing). 2024; 4(2):20210146.

PMID: 38855617 PMC: 11022630. DOI: 10.1002/EXP.20210146.


NIR-II light in clinical oncology: opportunities and challenges.

Zhang Z, Du Y, Shi X, Wang K, Qu Q, Liang Q Nat Rev Clin Oncol. 2024; 21(6):449-467.

PMID: 38693335 DOI: 10.1038/s41571-024-00892-0.


References
1.
Rao J, Dragulescu-Andrasi A, Yao H . Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol. 2007; 18(1):17-25. DOI: 10.1016/j.copbio.2007.01.003. View

2.
Hansch A, Frey O, Sauner D, Hilger I, Haas M, Malich A . In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum. 2004; 50(3):961-7. DOI: 10.1002/art.20112. View

3.
Tung C . Fluorescent peptide probes for in vivo diagnostic imaging. Biopolymers. 2004; 76(5):391-403. DOI: 10.1002/bip.20139. View

4.
Miller M, Kim E, Cuccarese M, Plotkin A, Prytyskach M, Kohler R . Near infrared imaging of Mer tyrosine kinase (MERTK) using MERi-SiR reveals tumor associated macrophage uptake in metastatic disease. Chem Commun (Camb). 2017; 54(1):42-45. PMC: 5736449. DOI: 10.1039/c7cc07581b. View

5.
Vouri M, Hafizi S . TAM Receptor Tyrosine Kinases in Cancer Drug Resistance. Cancer Res. 2017; 77(11):2775-2778. DOI: 10.1158/0008-5472.CAN-16-2675. View